Skip to main content
Oncology Letters logoLink to Oncology Letters
. 2017 Sep 8;14(5):6321. doi: 10.3892/ol.2017.6921

Proteasome inhibitors in glioblastoma

Wen-Juan Huang, Wei-Wei Chen, Xia Zhang
PMCID: PMC5661411  PMID: 29113284

Oncol Lett 13: 1058-1062, 2017; DOI: 10.3892/ol.2017.5585

Further to the publication of the above review article, the Editor of Oncology Letters was contacted by an interested reader who drew to our attention that an extensive overlap existed between the text of the review and the doctoral dissertion, ‘Induction of caspase-dependent death by proteasome targeted therapy in glioblastoma.’ 2015/05 http://digitalcommons.library.tmc.edu/utgsbs_dissertations/545/.

Following an investigation, the journal is able to confirm that parts from the review are identical with those featured in the 2015 dissertation. On those grounds, we are retracting the review from the publication. The Editor deeply regrets any inconvenience that this retraction has caused to the readership of the Journal.


Articles from Oncology Letters are provided here courtesy of Spandidos Publications

RESOURCES